Reporting owner · Q3 2026 · CIK 1920053

Navratil Tomas: insider trades.

Navratil Tomas reported 15 non-derivative transactions on 4 SEC ownership filings in Q3 2026: 0 open-market purchases and 15 sales ($3.1M), across 1 company.

Transactions
15
Purchases (P)
0
Sales (S)
15
Companies
1
Name as filed
Navratil Tomas

Companies

CompanyRelationshipTransactions
GLAUKOS Corp (GKOS)Officer · CHIEF DEVELOPMENT OFFICER15

Transactions

15 non-derivative rows. Shares and prices as filed.
DateCompanyCodeSharesPriceOwned afterFiling
2026-09-25GLAUKOS CorpS167$151.772,266Form 4
2026-09-25GLAUKOS CorpS136$152.7172,130Form 4
2026-09-25GLAUKOS CorpS229$154.2471,901Form 4
2026-09-25GLAUKOS CorpS1,083$154.8870,818Form 4
2026-09-16GLAUKOS CorpS103$163.273,787Form 4
2026-09-16GLAUKOS CorpS345$164.673,442Form 4
2026-09-16GLAUKOS CorpS191$166.273,251Form 4
2026-09-16GLAUKOS CorpS4$17272,433Form 4
2026-09-16GLAUKOS CorpS120$168.3872,671Form 4
2026-09-16GLAUKOS CorpS234$170.9572,437Form 4
2026-09-16GLAUKOS CorpS460$167.3272,791Form 4
2026-08-28GLAUKOS CorpS6,091$181.1973,900Form 4
2026-08-28GLAUKOS CorpS10$182.573,890Form 4
2026-08-28GLAUKOS CorpS7,643$180.2579,991Form 4
2026-07-01GLAUKOS CorpS716$139.0687,634Form 4

Questions

What stock did Navratil Tomas buy or sell?

Navratil Tomas reported 15 non-derivative transactions on 4 SEC ownership filings in Q3 2026: 0 open-market purchases and 15 sales ($3.1M), across 1 company.

Is Navratil Tomas the same person as other filers with this name?

This page covers SEC CIK 1920053 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.

Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.

Plain-text version for agents and LLMs: /insiders/navratil-tomas-1920053.md

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.